Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ken Garber

Showing results (181-190 of 194) with videos related to

Pageof 20
Sort By:
Nature Biotechnology|November 10, 2018
No added sugar: antibody makers find an upside to 'no fucose'Ken Garber
Nature Biotechnology|April 9, 2020
γδ T cells bring unconventional cancer-targeting to the clinic - againKen Garber
Nature Biotechnology|August 9, 2012
Genentech's Alzheimer's antibody trial to study disease preventionKen Garber
Nature Biotechnology|August 8, 2020
Histone-writer cancer drugs enter center stageKen Garber
Nature|September 28, 2012
Biochemistry: A radical treatmentKen Garber
Nature Biotechnology|August 19, 2024
Editor's pick: Cargo TherapeuticsKen Garber
Nature Biotechnology|May 17, 2023
Drugging RNAKen Garber
Nature Biotechnology|August 7, 2018
Erratum: Nature Biotechnology's academic spinouts of 2017Malorye Allison Branca, Ken Garber, Laura DeFrancesco
Nature Biotechnology|April 6, 2018
Nature Biotechnology's academic spinouts of 2017Malorye Allison Branca, Ken Garber, Laura DeFrancesco
Nature Biotechnology|November 4, 2022
Nature Biotechnology's academic spinouts 2021Michael Eisenstein, Ken Garber, Esther Landhuis, et al.
Pageof 20

Showing results (181-190 of 194) with videos related to

Sort By:
Pageof 20
Nature Biotechnology|November 10, 2018
No added sugar: antibody makers find an upside to 'no fucose'Ken Garber
Nature Biotechnology|April 9, 2020
γδ T cells bring unconventional cancer-targeting to the clinic - againKen Garber
Nature Biotechnology|August 9, 2012
Genentech's Alzheimer's antibody trial to study disease preventionKen Garber
Nature Biotechnology|August 8, 2020
Histone-writer cancer drugs enter center stageKen Garber
Nature|September 28, 2012
Biochemistry: A radical treatmentKen Garber
Nature Biotechnology|August 19, 2024
Editor's pick: Cargo TherapeuticsKen Garber
Nature Biotechnology|May 17, 2023
Drugging RNAKen Garber
Nature Biotechnology|August 7, 2018
Erratum: Nature Biotechnology's academic spinouts of 2017Malorye Allison Branca, Ken Garber, Laura DeFrancesco
Nature Biotechnology|April 6, 2018
Nature Biotechnology's academic spinouts of 2017Malorye Allison Branca, Ken Garber, Laura DeFrancesco
Nature Biotechnology|November 4, 2022
Nature Biotechnology's academic spinouts 2021Michael Eisenstein, Ken Garber, Esther Landhuis, et al.
Pageof 20